Live Breaking News & Updates on Biotechnology Companies Work To Advance Psychedelic Therapeutics

Research and Development Moves the Psychedelics Market Forward
- FN Media Group Presents Microsmallcap.com Market Commentary
NEW YORK, Jan. 27, 2021 /PRNewswire/ The ongoing surge of development and investment into psychedelic medicine and psychedelic-assisted therapy is the direct result of newfound public support and legitimacy for these revolutionary treatments. That legitimacy is being built on the back of a growing body of research showing the benefits of these treatments and the intense need for alternatives to legacy approaches to mental healthcare. The flood of research is continuing, most recently with an
ongoing study on psychosubstances as a potential treatment for veterans with PTSD. As more data supports the legitimacy of these treatments, companies that are commercializing psychedelic medicines, like ....

Kostenloser Wertpapierhandel , Rakesh Jetly , Joshua Bartch , Orbitrap Exploris , University Of Alberta , Tonix Pharmaceuticals , Fn Media Group , Mydecine Innovations Group , Mydecine Co , Hollister Biosciences Inc , National Psychotrauma Centre , Mydecine Innovations Group Inc , Numinus Wellness Inc , Biotechnology Companies Work To Advance Psychedelic Therapeutics , Exchange Commission , Leiden University Medical Center , Securities Exchange , Medicine Mindmed Inc , Fn Media Group Presents Microsmallcap , Group Presents Microsmallcap , Numinus Wellness , Hollister Biosciences , Mind Medicine , Innovations Group Moves , Psychedelics Space Forward , Innovations Group ,